Allos Therapeutics Overview
- Year Founded
-
1992
- Status
-
Acquired/Merged
- Employees
-
111
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
1
Allos Therapeutics General Information
Description
Provider of small molecule therapeutics for the treatment of cancer. The company develops a folate analogue metabolic inhibitor.
Contact Information
Formerly Known As
HemoTech Sciences
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- 11080 Circlepoint Road
- Suite 200
- Westminster, CO 80020
- United States
+1 (303) 000-0000
Allos Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Allos Therapeutics Patents
Allos Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2807484-A1 | Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin | Inactive | 10-Aug-2010 | 0000000000 | |
| EP-2603082-A1 | Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin | Inactive | 10-Aug-2010 | 0000000000 | |
| EP-2603082-A4 | Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin | Inactive | 10-Aug-2010 | 0000000000 | 0 |
| US-20130178441-A1 | Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin | Inactive | 10-Aug-2010 | 0000000000 | |
| AU-2011289638-B2 | Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin | Inactive | 10-Aug-2010 | A61K31/519 |
Allos Therapeutics Executive Team (7)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Bruce Bennett | Senior Vice President, Pharmaceutical Operations | ||
| Paul Berns | Chief Executive Officer & President | ||
| Stewart Hen | Director |
Allos Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Allos Therapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Allos Therapeutics Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0-0000 | 15-Apr-2002 | 000000000 | 000 | Drug Discovery |